Lilly TuneLab: federated AI/ML drug-discovery models for member biotechs (new models released October 2026)

Lilly TuneLab gives member biotech companies access to AI models trained on Lilly data and partner-contributed data. On October 6, 2026 insitro announced its in vivo pharmacokinetics models are available in TuneLab; Lilly's anniversary release added further small-molecule and antibody models. Access is through a membership process with the TuneLab team.